Clinical Trial Update: Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olaparib, cediranib maleate, and standard chemotherapy in extensive stage small cell lung carcinoma; study terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Cediranib Maleate (cediranib)
• Olaparib (Olaparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-04-19